Wednesday, July 06, 2016 11:34:47 AM
You may be right...
However there is a cost associated with being a viable shell, and for those companies that are in the small range with revenues under 15mm it might make sense. Certainly it would make sense for insider holders (however many mm's of shares are held restricted or in inventory) to award to a new company who can thake this forward with enough force so that the total )shares and new cap and opportunity) equal a real meaningful return for holders.
I look to see if the principals are stakeholders in current common. We all got shafted with the RS which really means we need to see a share price at .15 - .20 cents and more to even get close to even from JUST the reverse not to speak of restoring the damage to value that past companies mgt (Vencor with Vega and Plad) did to common holders. The amazing thing is that for all the delays and PS work and two company mgts we are worse off (value wise) then we were at the beginning 3 years ago.
I do feel that the current mgt has also suffered in this -has lots of money out so has a interest in seeing a real return. Whether that includes current and past common holders (via losses and valuations) or not is another matter...
Be nice to get some mid term update...or public sign things are moving
However there is a cost associated with being a viable shell, and for those companies that are in the small range with revenues under 15mm it might make sense. Certainly it would make sense for insider holders (however many mm's of shares are held restricted or in inventory) to award to a new company who can thake this forward with enough force so that the total )shares and new cap and opportunity) equal a real meaningful return for holders.
I look to see if the principals are stakeholders in current common. We all got shafted with the RS which really means we need to see a share price at .15 - .20 cents and more to even get close to even from JUST the reverse not to speak of restoring the damage to value that past companies mgt (Vencor with Vega and Plad) did to common holders. The amazing thing is that for all the delays and PS work and two company mgts we are worse off (value wise) then we were at the beginning 3 years ago.
I do feel that the current mgt has also suffered in this -has lots of money out so has a interest in seeing a real return. Whether that includes current and past common holders (via losses and valuations) or not is another matter...
Be nice to get some mid term update...or public sign things are moving
Recent BLEG News
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • InvestorsHub NewsWire • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • GlobeNewswire Inc. • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • InvestorsHub NewsWire • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • GlobeNewswire Inc. • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • GlobeNewswire Inc. • 12/10/2025 02:17:29 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • InvestorsHub NewsWire • 12/10/2025 02:00:00 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • GlobeNewswire Inc. • 11/25/2025 03:38:40 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • InvestorsHub NewsWire • 11/25/2025 03:11:49 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • InvestorsHub NewsWire • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • GlobeNewswire Inc. • 10/22/2025 03:17:40 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • InvestorsHub NewsWire • 10/22/2025 02:56:16 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • InvestorsHub NewsWire • 09/30/2025 12:30:00 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • GlobeNewswire Inc. • 09/23/2025 02:44:55 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • InvestorsHub NewsWire • 09/23/2025 01:40:59 PM
- Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions • InvestorsHub NewsWire • 08/22/2025 05:39:40 PM
- Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways • InvestorsHub NewsWire • 08/19/2025 12:39:04 PM
- Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery • InvestorsHub NewsWire • 07/29/2025 12:30:00 PM
- Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • InvestorsHub NewsWire • 07/14/2025 05:23:12 PM
